Landos Biopharma Inc (LABP)
22.21
-0.26
(-1.16%)
USD |
NASDAQ |
May 20, 16:00
22.21
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
--
Maximum
Jun 2021
--
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
AbbVie Inc | 9.242 |
Fusion Pharmaceuticals Inc | -- |
Masimo Corp | 0.6417 |
Kinnate Biopharma Inc (DELISTED) | -- |
Invivyd Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 29.90M |
Total Liabilities (Quarterly) | 6.742M |
Shareholders Equity (Quarterly) | 23.15M |